HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 1

Part of paid clinical trials in West Haven, Connecticut.

Sponsor
Yale University
Study ID
NCT05560932
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • IMB-motivational interviewing (MI) techniques (IMB-MI) — BEHAVIORAL
    The clinical pharmacist will employ MI in informational, participant-centered discussions in which the clinical pharmacist and participant collaboratively discuss the harms of drinking and polypharmacy (specifically alcohol interactive medications), symptoms associated with alcohol and specific medications, and how to mitigate these harms. Motivational elements include messages highlighting the participant's personal risk of bothersome symptoms from their use of alcohol and level of polypharmacy, attitude change elements to improve attitudes toward the intended behavior change, social normative support for the intended behavior change including identification of people who can support the participant in this process, and a menu of options for referrals for skill building (e.g. Social Work, meeting with the clinical pharmacist at their clinic, follow-up with the HIV clinician, alcohol-reduction programs, based on what is locally available as part of VA-based care).

Study Details

This pilot intervention will consist of a brief intervention for patients with HIV who take 5 or more medications and currently (within the past month) consume alcohol. The focus of this pilot will be on bothersome symptoms and the impact of alcohol use and medications on these symptoms. The rationale is that any alcohol use may interact with medications in serious ways leading to adverse outcomes, including bothersome symptoms.

Key Dates

Start date
Mar 6, 2023
Status verified
Jun 2025
Primary completion
Jan 4, 2024
Completion
Jan 4, 2024

Study Design

Enrollment
50 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION

Arms

  • Experimental: HIV Medications and Alcohol Use
    Participants with HIV who take 5 or more medications and currently (within the past month) consume alcohol

Primary Outcome Measure

Enrollment to Assess Feasibility [ Time Frame: baseline ]

Locations (1)

FacilityCityStateZIPSite coordinators
West Haven CT Veterans AdministrationWest HavenConnecticut06516-

Find similar trials in West Haven, CT

By condition
HIV
By specialty
Infectious disease
By research site
West Haven CT Veterans Administration· West Haven, CT

Related Studies